ES434618A1 - Medicament carrier - Google Patents

Medicament carrier

Info

Publication number
ES434618A1
ES434618A1 ES434618A ES434618A ES434618A1 ES 434618 A1 ES434618 A1 ES 434618A1 ES 434618 A ES434618 A ES 434618A ES 434618 A ES434618 A ES 434618A ES 434618 A1 ES434618 A1 ES 434618A1
Authority
ES
Spain
Prior art keywords
eye
glucosamine
acetyl
poly
controlled release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES434618A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ES434618A1 publication Critical patent/ES434618A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A controlled release insert for a living eye consisting of a biologically effective form of pilocarpine and a biologically inert biodegradable carrier consisting essentially of poly[N-acetyl-6-O-(carboxymethyl)-D-glucosamine] gives effective treatment to the human eye for prolonged periods. Other medicaments and other enzymatically degradable forms of poly(N-acetyl-D-glucosamine) may be used for rate controlled release in the eye and other areas.
ES434618A 1974-02-11 1975-02-11 Medicament carrier Expired ES434618A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US441695A US3911098A (en) 1974-02-11 1974-02-11 Medicament carrier

Publications (1)

Publication Number Publication Date
ES434618A1 true ES434618A1 (en) 1977-04-16

Family

ID=23753927

Family Applications (1)

Application Number Title Priority Date Filing Date
ES434618A Expired ES434618A1 (en) 1974-02-11 1975-02-11 Medicament carrier

Country Status (19)

Country Link
US (1) US3911098A (en)
JP (1) JPS50123815A (en)
AR (1) AR206618A1 (en)
BE (1) BE825367A (en)
CA (1) CA1045975A (en)
CS (1) CS207808B1 (en)
DD (1) DD118801A5 (en)
DE (1) DE2505305A1 (en)
ES (1) ES434618A1 (en)
FR (1) FR2260356B1 (en)
GB (1) GB1499751A (en)
IL (1) IL46496A (en)
IT (1) IT1036866B (en)
NL (1) NL7501365A (en)
PH (1) PH13485A (en)
PL (1) PL177948A1 (en)
RO (1) RO68711A (en)
SE (1) SE7501464L (en)
ZA (1) ZA75472B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL188266C (en) * 1975-07-29 1992-05-18 Merck & Co Inc PROCESS FOR THE PREPARATION OF AN ORGANIC IMPLANT.
US4066747A (en) * 1976-04-08 1978-01-03 Alza Corporation Polymeric orthoesters housing beneficial drug for controlled release therefrom
EP0000291B1 (en) * 1977-06-28 1981-09-30 University of Strathclyde A pharmaceutical composition for tropical diseases
US4287175A (en) * 1978-06-22 1981-09-01 Merck & Co., Inc. Contact lens wetting agents
JPS57134412A (en) * 1981-02-12 1982-08-19 Unitika Ltd Biodegradable drug donor
DE3360633D1 (en) * 1982-02-12 1985-10-03 Unitika Ltd Anti-cancer device
US5277900A (en) * 1982-08-07 1994-01-11 Henkel Kommanditgesellschaft Auf Aktien Method for blood coagulation on hard tissues
JPS6036410A (en) * 1983-08-08 1985-02-25 Unitika Ltd Preparation of donor of biodegradable drug
US5290752A (en) * 1984-03-16 1994-03-01 Unitika Ltd. Method for preparation of a shaped chitin body containing a physiologically active substance
JPH0623091B2 (en) * 1984-03-16 1994-03-30 ユニチカ株式会社 Chitin molding manufacturing method
JPS62193638A (en) * 1986-02-20 1987-08-25 Kao Corp Granular agent
US4931551A (en) * 1988-07-05 1990-06-05 University Of Delaware Dispersions of chitin and product therefrom
AU2572692A (en) 1991-09-09 1993-04-05 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods and devices for treating hemophilia and aids
US5383873A (en) * 1992-12-09 1995-01-24 Regents Of The University Of Minnesota Smooth muscle chemical pacemaker
US5741329A (en) * 1994-12-21 1998-04-21 Board Of Regents, The University Of Texas System Method of controlling the pH in the vicinity of biodegradable implants
US6065476A (en) * 1994-12-21 2000-05-23 Board Of Regents, University Of Texas System Method of enhancing surface porosity of biodegradable implants
US6767899B1 (en) * 2000-08-29 2004-07-27 Leiner Health Services Corp. Composition and method for treatment of conditions having an inflammatory component
US7018646B2 (en) * 2002-05-30 2006-03-28 Van Dalen Johan T W Apparatus and method for delivering controlled quantities of one or more agents to the eye
US7699863B2 (en) * 2005-03-01 2010-04-20 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
US7785291B2 (en) * 2005-03-01 2010-08-31 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
DK2858604T3 (en) 2012-06-07 2024-05-21 Epitomee Medical Ltd EXPANDED DEVICE
US9320645B2 (en) 2013-05-29 2016-04-26 Terry Glasser Approach to administering ocular medication
WO2015083171A1 (en) 2013-12-05 2015-06-11 Tulip Medical Ltd. Retentive devices and systems for in-situ release of pharmaceutical active agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2040879A (en) * 1934-06-21 1936-05-19 Du Pont Substantially undegraded deacetylated chitin and process for producing the same
US2040880A (en) * 1934-06-21 1936-05-19 Du Pont Process for the preparation of films and filaments and products thereof
US2168374A (en) * 1936-07-09 1939-08-08 Visking Corp Chemical compounds and products produced therefrom
US3632754A (en) * 1968-02-12 1972-01-04 Lescarden Ltd Use of chitin for promoting wound healing
US3736646A (en) * 1971-10-18 1973-06-05 American Cyanamid Co Method of attaching surgical needles to multifilament polyglycolic acid absorbable sutures
US3845201A (en) * 1972-04-24 1974-10-29 S Loucas Solid state ophthalmic medication delivery method

Also Published As

Publication number Publication date
NL7501365A (en) 1975-08-13
GB1499751A (en) 1978-02-01
CS207808B1 (en) 1981-08-31
PH13485A (en) 1980-05-21
RO68711A (en) 1980-10-30
PL177948A1 (en) 1978-04-10
DE2505305A1 (en) 1975-08-21
FR2260356A1 (en) 1975-09-05
IT1036866B (en) 1979-10-30
US3911098A (en) 1975-10-07
SE7501464L (en) 1975-08-12
DD118801A5 (en) 1976-03-20
IL46496A0 (en) 1975-06-25
IL46496A (en) 1978-08-31
FR2260356B1 (en) 1978-07-28
BE825367A (en) 1975-08-11
AR206618A1 (en) 1976-08-06
JPS50123815A (en) 1975-09-29
ZA75472B (en) 1976-01-28
CA1045975A (en) 1979-01-09
AU7760275A (en) 1976-07-29

Similar Documents

Publication Publication Date Title
ES434618A1 (en) Medicament carrier
ES8307845A1 (en) Continuous release pharmaceutical compositions.
ES414976A1 (en) Artificial tooth implant device
ES8608848A1 (en) Intra pocket drug delivery devices for treatment of periondontal diseases.
IE781163L (en) Sustained release of veterinary medicaments
MX9602656A (en) Transdermal device containing polyvinylpyrrolidone as solubility enhancer.
UA29563C2 (en) Microcapsule for prolonged release of physiologically active peptide
CA2125579A1 (en) Ulcer prevention treatment composition and method
FR2290891A1 (en) SUPPORT INTENDED TO SLOWLY RELEASE AN ACTIVE BODY, IN PARTICULAR A MEDICINAL PRODUCT, AND ITS MANUFACTURE
UA34419C2 (en) Lyophilised injectable preparation and method for tumour growth inhibition
HU912442D0 (en) Process for the production of medical preparations with continuous active agent release
ATE51342T1 (en) AGENT AND DEVICE FOR CONTROLLING THE TRANSDERMAL PENETRATION OF TOPICAL AND SYSTEMATIC AGENTS.
EP0297535A3 (en) Drug delivery devices
IL115138A0 (en) Implantable polymer-containing molded articles for the administration of active substances to plants and processes for the preparation thereof
CA2251966A1 (en) Transdermally administered dextromethorphan as antitussive agent
ES2099708T3 (en) A MEDICINAL SUBSTANCE FOR TOPICAL APPLICATION.
HU901422D0 (en) Process for the manufacturing of plaster with skin penetrating active agnet
EP0019403A3 (en) Hydroxyalkyl-starch drug carrier and method of administering a biologically active compound to an animal
IE781117L (en) Medicament comprising erythromycin and metoclopramide
DE3268159D1 (en) Medicaments based on algae, and formulations thereof
ES459244A1 (en) Sustained release ophthalmic pharmaceutical preparations containing collagens
GB1141271A (en) Hemostatic material
WO1987007836A3 (en) Medicament and medicinal composition for the treatment of infectious diseases due to viruses, as well as for the treatment of tumors
EP0340933A3 (en) Heparin-containing formulations
FR2668367B1 (en) IMPLANTABLE MEDICINE WITH PROLONGED EFFECT.